Identification of ABR-215050 as lead second generation quinoline-3- carboxamide anti-angiogenic agent for the treatment of prostate cancer

John T. Isaacs, Roberto Pili, David Z. Qian, Susan L. Dalrymple, Jason B. Garrison, Natasha Kyprianou, Anders Björk, Anders Olsson, Tomas Leanderson

Research output: Contribution to journal › Article › peer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'Identification of ABR-215050 as lead second generation quinoline-3- carboxamide anti-angiogenic agent for the treatment of prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences